Wednesday, April 20, 2016
Charles River Laboratories International has entered into a strategic partnership with BioMotiv, the therapeutic accelerator company associated with The Harrington Project for Discovery & Development. Charles River will provide discovery and preclinical development services that will enable BioMotiv to advance discoveries sourced from academic research and non-governmental organizations into novel medicines.
InVentiv Health has filed paperwork for an initial public offering (IPO) worth up to $100 million, following in the footsteps of three other large private equity-backed CROs that have gone public in recent years. Analysts see strong financial activity on the horizon for the CRO industry.
Pharmaceutical and medical device teams plan to increasingly involve CROs in their clinical trial planning processes. The largest projected change is the level of vendor involvement in trial design activities, according to a recent report issued by pharmaceutical intelligence provider Cutting Edge Information.
Parexel International, a global biopharmaceutical services organization, and EMC have entered into an alliance to offer an end-to-end Regulatory Information Management (RIM) and Regulatory Content Management solution.
Snapdragon Chemistry has moved to new lab facilities in Cambridge, Massachusetts. Snapdragon’s corporate partner, Zaiput Flow Technologies, has also moved to the 85 Bolton Street site. This co-location will enhance the collaboration of these strategic partners and accelerate the development of advanced continuous chemical manufacturing technologies and solutions.
ALTEN Calsoft Labs, a global provider of enterprise IT and product engineering, has acquired U.S.-based CRO services company PVR Technologies and its subsidiaries. ALTEN Calsoft Labs, a subsidiary of ALTEN Group, works with healthcare and life science companies in their strategic product engineering, IT and digital initiatives.
AAIPharma Services (AAI) and Cambridge Major Laboratories (CML) are now Alcami, a new brand and identity as a contract development and manufacturing organization (CDMO) with expanded capabilities and capacity.
Biodextris, a Canada-based CRO, has launched. The new CRO provides analytical and process development services for vaccines and biologics products.
Eurotrials, a CRO specialized in Europe and Latin America, is pleased to announce the opening of its new office in Mexico City, Mexico. The new office strengthens the company’s presence in Latin America and further boosts its growth and expansion, providing full operational coverage in this key emergent region.